Cancer Causes & Control

, Volume 5, Issue 5, pp 433–439 | Cite as

Longchain serum fatty acids and risk of thyroid cancer: A population-based case-control study in Norway

  • Jens P. Berg
  • Eystein Glattre
  • Tor Haldorsen
  • Arne T. Høstmark
  • Ida G. Bay
  • Aage F. Johansen
  • Egil Jellum
Research Papers


Epidemiologic studies have shown an association between seafood consumption and risk of thyroid cancer. Fish meals increase the serum concentrations of the longchain fatty acids, eicosapentaenoic acid (20∶5,n-3) (EPA) and docosahexaenoic acid (22∶6,n-3) (DHA), for days. The hypothesis that serum concentrations of fatty acids may be associated with thyroid cancer risk therefore was tested in a population-based case-control study with 74 cases and 221 matched controls. Seventy-three cases with sera in the Norwegian serum bank (JANUS) were identified in the Norwegian Cancer Registry and matched with three controls, also in JANUS, on age, gender, place of residence, and time of blood sampling. Each case was matched with two controls. Serum concentrations of 11 longchain fatty acids were determined blindly by gas chromatography for all subjects. Controls were divided into three groups with increasing serum fatty acid concentrations, and odds ratios between cases and controls were estimated relative to the group with lowest serum level by univariate and multivariate analyses. The main finding was a significant inverse relation between the sum of arachidonic acid (20∶4,n-6) (AA) and DHA serum concentrations and thyroid cancer risk. The significance of this association was weakened when the analyses were restricted to the papillary type of thyroid carcinoma. It was of the same order of magnitude whether the period between blood sampling and diagnosis was greater than eight years, or eight or less years. High EPA/AA ratio, indicating consumption of fish fat, was not associated significantly with increased thyroid-cancer risk. These data indicate that the association between seafood ingestion and increased thyroid-cancer risk may not be caused by the marine fatty acids.

Key words

Arachidonic acid docosahexaenoic acid case-control study Norway polyunsaturated fatty acids risk reduction thyroid cancer 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J eds.Cancer Incidence in Five Continents. Volume VI. Lyon, France: International Agency for Research on Cancer, 1992; IARC Sci. Pub. No. 120.Google Scholar
  2. 2.
    Glattre E, Thoresen SØ, Jebsen JW. Thyroid cancer: High risk areas in northern Norway. In: Låg J, ed.:Excess and Deficiency of Trace Elements in Relation to Human and Animal Health in Arctic and Subarctic region, Oslo, Norway: The Norwegian Academy of Science and Letters, 1990: 149–57.Google Scholar
  3. 3.
    Belfiore A, La Rosa GL, Padova G, Sava L, Ippolito O, Vigneri R. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area.Cancer 1987:60: 3096–112.PubMedGoogle Scholar
  4. 4.
    Ron E, Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT, Fraumeni JF Jr. A population-based case-control study of thyroid cancer.JNCI 1987;79: 1–12.PubMedGoogle Scholar
  5. 5.
    Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW. An epidemiologic study of thyroid cancer in Hawaii.Cancer Causes Control 1990;1: 223–34.PubMedGoogle Scholar
  6. 6.
    Glattre E, Haldorsen T, Berg JP, Stensvold I, Solvoll K. Norwegian case-control study testing the hypothesis that seafood increases the risk of thyroid cancer.Cancer Causes Control 1993;4: 11–6.PubMedGoogle Scholar
  7. 7.
    Franceschi S, Fassina A, Talamini R, et al. Risk factors for thyroid cancer in Northern Italy.Int J Epidemiol 1989;18: 578–84.PubMedGoogle Scholar
  8. 8.
    Bønaa KH, Bjerve KS, Nordøy A. Habitual fish consumption, plasma phospholipid fatty acids, and serum lipids. The Tromsø study.Am J Clin Nutr 1992;55: 1126–34.PubMedGoogle Scholar
  9. 9.
    Jellum E, Andersen A, Ørjasæter H, Foss OP, Theodorsen L, Lund-Larsen P. The JANUS serum bank and early detection of cancer.Biochem Clin 1987;11: 191–5.Google Scholar
  10. 10.
    Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Ørjasæter H. The JANUS serum bank.Sci Total Environ 1993;139/140: 527–35.Google Scholar
  11. 11.
    Vatten LJ, Bjerve KS, Andersen A, Jellum E. Polyunsaturated fatty acids in serum phospholipids and risk of breast cancer: A case-control study from the JANUS serum bank in Norway.Eur J Cancer 1993;29A: 532–8.PubMedGoogle Scholar
  12. 12.
    Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues.J Biol Chem. 1957;226: 497–509.PubMedGoogle Scholar
  13. 13.
    Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol.Lipid Res 1964;5: 600–8.Google Scholar
  14. 14.
    Preston DL, Lubin JH, Pierce DA.EPICURE. User's Guide. Seattle, WA (USA): HiroSoft International Corporation, 1988–93.Google Scholar
  15. 15.
    Krokan HE, Bjerve KS, Mork E. The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro.Biochim Biophys Acta 1993;1168: 59–67.PubMedGoogle Scholar
  16. 16.
    Søyland E, Funk J, Raijka G, et al. Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis.N Engl J Med 1993;328: 1812–6.PubMedGoogle Scholar
  17. 17.
    James MJ, Gibson RA, D'Angelo M, Neumann MA, Cleland LG. Simple relationships exist between dietary linoleate and the n-6 fatty acids of human neutrophils and plasma.Am J Clin Nutr 1993;58: 497–500.PubMedGoogle Scholar
  18. 18.
    Glattre E, Akslen LA, Thoresen SØ, Haldorsen T. Geographic patterns and trends in the incidence of thyroid cancer in Norway 1970–1986.Cancer Detect Prev 1990;14: 625–31.PubMedGoogle Scholar
  19. 19.
    Kravdal Ø, Glattre E, Haldorsen T. Positive correlation between parity and incidence of thyroid cancer. New evidence based on complete Norwegian birth cohorts.Int J Cancer 1991;49: 831–6.PubMedGoogle Scholar
  20. 20.
    Neuringer M, Connor WE. N-3 fatty acids in the brain and retina: Evidence for their essentiality.Nutr Rev 1986;44: 285–94.PubMedGoogle Scholar
  21. 21.
    Carsol SE, Cooke RJ, Rhodes PG, Pepples JM, Werkman SH. Effect of vegetable and marine oils in preterm infant formulas on blood arachidonic and docosahexaenoic acids.J Pediatr 1992;120: S159–67.Google Scholar
  22. 22.
    Dugrillon A, Gärtner R. The role of iodine and thyroid cell growth.Thyroidol Clin Exp 1992;4: 31–6.PubMedGoogle Scholar
  23. 23.
    Wolff J. Excess iodide inhibits the thyroid by multiple mechanisms. In: Ekholm R, Kohn LD, Wollman SH, eds.Control of the Thyroid Gland: Regulation of its Normal Function and Growth. New York, NY (USA): Plenum Press, 1989: 211–44.Google Scholar
  24. 24.
    Boeymaems J-M, Hubbard WC. Transformation of arachidonic acid into an iodolactone by the rat thyroid.J Biol Chem 1980;255: 9001–4.PubMedGoogle Scholar
  25. 25.
    Dugrillon A, Bechtner G, Uedelhoven WM, Weber PC, Gärtner R. Evidence that an iodolactone mediates the inhibitory effect of iodide on thyroid cell proliferation but not on adenosine 3′,5′-monophosphate formation.Endocrinology, 1990;127: 337–43.PubMedGoogle Scholar
  26. 26.
    Høstmark AT, Lystad E. Growth inhibition of human hepatoma cells (HepG2) by polyunsaturated fatty acids. Protection by albumin and vitamin E.Acta Physiol Scand 1992;144: 83–8.PubMedGoogle Scholar
  27. 27.
    Bégin ME, Eils G, Das UN, Horrobin DF. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids.JNCI 1986;77: 1053–62.PubMedGoogle Scholar
  28. 28.
    Gonzalez MJ, Schemmel RA, Dugan Jr L, Gray JI, Welsch CW. Dietary fish oil inhibits human breast carcinoma growth: A function of increased lipid peroxidation.Lipids 1993;28: 827–32.PubMedGoogle Scholar
  29. 29.
    Shinomura T, Asaoka Y, Oka M, Yoshida K, Nishizuka Y. Synergistic action of diacylglycerol and unsaturated fatty acid for protein kinase C (PKC) activation: its possible implications.Proc Natl Acad Sci USA 1991;88: 5149–53.PubMedGoogle Scholar
  30. 30.
    Borras M, Leclercq G. Modulatory effect of nonesterified fatty acids on structure and binding characteristics of estrogen receptor from MCF-7 human breast cancer cells.J Recept Res 1992;12: 463–84.PubMedGoogle Scholar
  31. 31.
    Ree AH, Landmark BF, Walaas SI, et al.: Down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors by phorbol ester and calcium in MCF-7 cells.Endocrinology 1991;129: 339–44.PubMedGoogle Scholar
  32. 32.
    Akslen LA, Haldorsen T, Thoresen SØ, Glattre E Incidence of thyroid cancer in Norway 1970–1985.APMIS 1990;98: 549–58.PubMedGoogle Scholar
  33. 33.
    Chaudhuri PK, Prinz RA. Estrogen receptor in normal and neoplastic human thyroid tissue.Am J Otolaryngol 1989;10: 322–6.PubMedGoogle Scholar

Copyright information

© Rapid Communications of Oxford Ltd 1994

Authors and Affiliations

  • Jens P. Berg
    • 1
    • 2
  • Eystein Glattre
    • 3
  • Tor Haldorsen
    • 3
  • Arne T. Høstmark
    • 4
  • Ida G. Bay
    • 4
  • Aage F. Johansen
    • 3
  • Egil Jellum
    • 5
  1. 1.Hormone LaboratoryAker HospitalOsloNorway
  2. 2.Department of Tissue Culture, Institute of Cancer ResearchThe Norwegian Radium HospitalOsloNorway
  3. 3.Norwegian Cancer RegistryOsloNorway
  4. 4.Department of Preventive MedicineUniversity of OsloNorway
  5. 5.Department of Clinical BiochemistryUniversity of Oslo, RikshospitaletOsloNorway

Personalised recommendations